W K Cavenee Selected Research

Ethylnitrosourea (N-Ethyl-N-nitrosourea)

1/2000

SETA: a novel SH3 domain-containing adapter molecule associated with malignancy in astrocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W K Cavenee Research Topics

Disease

13	Neoplasms (Cancer) 07/2015 - 02/2000
9	Glioma (Gliomas) 05/2014 - 01/2000
8	Glioblastoma (Glioblastoma Multiforme) 07/2015 - 07/2000
2	Brain Neoplasms (Brain Tumor) 05/2014 - 12/2001
2	Prostatic Neoplasms (Prostate Cancer) 01/2001 - 05/2000
1	Carcinogenesis 05/2014
1	Cerebral Hemorrhage 12/2001
1	Rupture 12/2001
1	Necrosis 07/2001
1	Alveolar Rhabdomyosarcoma 02/2001
1	Oligodendroglioma 01/2000
1	Astrocytoma (Pilocytic Astrocytoma) 01/2000

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 07/2015 - 01/2001
5	epidermal growth factor receptor VIIIIBA 07/2015 - 07/2001
4	DNA (Deoxyribonucleic Acid)IBA 09/2012 - 02/2000
3	Phosphotransferases (Kinase)IBA 05/2014 - 07/2001
3	Cisplatin (Platino)FDA LinkGeneric 09/2001 - 02/2000
2	Epidermal Growth Factor (EGF)IBA 07/2015 - 07/2001
2	Proteins (Proteins, Gene)FDA Link 05/2014 - 02/2001
2	Monoclonal AntibodiesIBA 07/2001 - 07/2001
2	monoclonal antibody 806IBA 07/2001 - 07/2001
1	src-Family KinasesIBA 07/2015
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 05/2014
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 05/2014
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 05/2014
1	protein kinase modulatorIBA 05/2014
1	Serine (L-Serine)FDA Link 05/2014
1	KT 5720IBA 05/2014
1	JNK Mitogen-Activated Protein KinasesIBA 09/2012
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 09/2012
1	InterleukinsIBA 09/2012
1	Interleukin-8 (Interleukin 8)IBA 09/2012
1	CytokinesIBA 09/2012
1	Protein Tyrosine PhosphatasesIBA 12/2001
1	Mitogen-Activated Protein KinasesIBA 12/2001
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2001
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2001
1	Protein Isoforms (Isoforms)IBA 12/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2001
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 09/2001
1	RTKI cpdIBA 09/2001
1	TyrphostinsIBA 09/2001
1	deoxyuridine triphosphateIBA 09/2001
1	Tyrosine Kinase InhibitorsIBA 09/2001
1	Amino Acids FDA Link 07/2001
1	DNA-Binding Proteins (DNA Binding Protein)IBA 06/2001
1	SilverIBA 05/2001
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2001
1	AnnexinsIBA 01/2001
1	Peptides (Polypeptides)IBA 07/2000
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2000
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2000
1	Somatomedin Receptors (Somatomedin Receptor)IBA 05/2000
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2000
1	Etoposide (VP 16)FDA LinkGeneric 02/2000
1	LigandsIBA 02/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2000
1	Death Domain ReceptorsIBA 02/2000
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 02/2000
1	Messenger RNA (mRNA)IBA 01/2000
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2000
1	CarcinogensIBA 01/2000

Therapy/Procedure

3	Therapeutics 07/2015 - 07/2000
1	Drug Therapy (Chemotherapy) 06/2001